A citation-based method for searching scientific literature

Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno, Clara Curiel-Lewandrowski, Femke A de Snoo, Tadeusz Debniak, Marie-France Demierre, David Elder, Alisa M Goldstein, Jane Grant-Kels, Allan C Halpern, Christian Ingvar, Richard F Kefford, Julie Lang, Rona M MacKie, Graham J Mann, Kurt Mueller, Julia Newton-Bishop, Håkan Olsson, Gloria M Petersen, Susana Puig, Darrell Rigel, Susan M Swetter, Margaret A Tucker, Emanuel Yakobson, John A Zitelli, Hensin Tsao. J Am Acad Dermatol 2009
Times Cited: 109







List of co-cited articles
711 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
260
43

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
280
34

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
339
32

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
331
22

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
283
21

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
613
19

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
19

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Colin B Begg, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti,[...]. J Natl Cancer Inst 2005
146
19

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Roberto Zanetti, Cinzia Masini, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
444
18

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
22


TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
17

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
N Soufir, M F Avril, A Chompret, F Demenais, J Bombled, A Spatz, D Stoppa-Lyonnet, J Bénard, B Bressac-de Paillerets. Hum Mol Genet 1998
309
16

Identification, genetic testing, and management of hereditary melanoma.
Sancy A Leachman, Olivia M Lucero, Jone E Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo. Cancer Metastasis Rev 2017
55
29

Role of the CDKN2A locus in patients with multiple primary melanomas.
Susana Puig, Josep Malvehy, Cèlia Badenas, Anna Ruiz, Dolores Jimenez, Francisco Cuellar, Antoni Azon, Urbá Gonzàlez, Teresa Castel, Antoni Campoy,[...]. J Clin Oncol 2005
106
15


POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
224
15

Update in genetic susceptibility in melanoma.
Miriam Potrony, Celia Badenas, Paula Aguilera, Joan Anton Puig-Butille, Cristina Carrera, Josep Malvehy, Susana Puig. Ann Transl Med 2015
99
14

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Orietta Picconi, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
751
13

Population-based analysis of prognostic factors and survival in familial melanoma.
Scott R Florell, Kenneth M Boucher, Gilda Garibotti, John Astle, Richard Kerber, Geraldine Mineau, Charles Wiggins, R Dirk Noyes, Alexander Tsodikov, Lisa A Cannon-Albright,[...]. J Clin Oncol 2005
69
18

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
118
13

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Paola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, Linda Battistuzzi, Fiorenza Belli, Loris Bernard, Luigina Bonelli, Giacomo Borgonovo, William Bruno, Franco De Cian,[...]. J Med Genet 2012
50
26

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
104
13

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Damiano Abeni, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
492
12

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
A Kamb, D Shattuck-Eidens, R Eeles, Q Liu, N A Gruis, W Ding, C Hussey, T Tran, Y Miki, J Weaver-Feldhaus. Nat Genet 1994
523
12


Clinical genetic testing for familial melanoma in Italy: a cooperative study.
William Bruno, Paola Ghiorzo, Linda Battistuzzi, Paolo A Ascierto, Monica Barile, Sara Gargiulo, Francesca Gensini, Sara Gliori, Michele Guida, Maurizio Lombardo,[...]. J Am Acad Dermatol 2009
34
35

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
V Nikolaou, X Kang, A Stratigos, H Gogas, M C Latorre, M Gabree, M Plaka, C N Njauw, K Kypreou, I Mirmigi,[...]. Br J Dermatol 2011
28
42

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
F Demenais, H Mohamdi, V Chaudru, A M Goldstein, J A Newton Bishop, D T Bishop, P A Kanetsky, N K Hayward, E Gillanders, D E Elder,[...]. J Natl Cancer Inst 2010
76
15

CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
Lisa G Aspinwall, Samantha L Leaf, Erin R Dola, Wendy Kohlmann, Sancy A Leachman. Cancer Epidemiol Biomarkers Prev 2008
52
23

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
203
12

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Miriam Potrony, Joan Anton Puig-Butillé, Paula Aguilera, Celia Badenas, Cristina Carrera, Josep Malvehy, Susana Puig. J Am Acad Dermatol 2014
36
33

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
A Borg, T Sandberg, K Nilsson, O Johannsson, M Klinker, A Måsbäck, J Westerdahl, H Olsson, C Ingvar. J Natl Cancer Inst 2000
249
11

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013
458
11

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
118
11

Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Efthymia Soura, Philip J Eliades, Kristen Shannon, Alexander J Stratigos, Hensin Tsao. J Am Acad Dermatol 2016
87
12

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
G Della Torre, B Pasini, S Frigerio, R Donghi, D Rovini, D Delia, G Peters, T J Huot, G Bianchi-Scarra, F Lantieri,[...]. Br J Cancer 2001
49
20

High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.
Michela Mantelli, Monica Barile, Paola Ciotti, Paola Ghiorzo, Francesca Lantieri, Lorenza Pastorino, Caterina Catricalà, Gabriella Della Torre, Ugo Folco, Paola Grammatico,[...]. Am J Med Genet 2002
61
16

Clinical germline genetic testing for melanoma.
Christopher B Hansen, Lisa M Wadge, Katrina Lowstuter, Kenneth Boucher, Sancy A Leachman. Lancet Oncol 2004
36
27

Final version of 2009 AJCC melanoma staging and classification.
Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Michael B Atkins, David R Byrd, Antonio C Buzaid, Alistair J Cochran, Daniel G Coit, Shouluan Ding,[...]. J Clin Oncol 2009
10

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
193
10

Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma.
Lucia Pedace, Paola De Simone, Marco Castori, Isabella Sperduti, Vitaliano Silipo, Laura Eibenschutz, Carmelilia De Bernardo, Pierluigi Buccini, Elvira Moscarella, Chiara Panetta,[...]. Cancer Epidemiol 2011
19
52

Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
Eve Maubec, Valérie Chaudru, Hamida Mohamdi, Christophe Blondel, Patricia Margaritte-Jeannin, Sébastien Forget, Eve Corda, Françoise Boitier, Stéphane Dalle, Pierre Vabres,[...]. J Am Acad Dermatol 2012
19
52

Genetics of familial melanoma: 20 years after CDKN2A.
Lauren G Aoude, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward. Pigment Cell Melanoma Res 2015
83
12

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
L Pastorino, L Bonelli, P Ghiorzo, P Queirolo, L Battistuzzi, E Balleari, S Nasti, S Gargiulo, S Gliori, P Savoia,[...]. Pigment Cell Melanoma Res 2008
40
22

MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
Sara Raimondi, Francesco Sera, Sara Gandini, Simona Iodice, Saverio Caini, Patrick Maisonneuve, Maria Concetta Fargnoli. Int J Cancer 2008
233
9

Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling.
Lisa G Aspinwall, Samantha L Leaf, Wendy Kohlmann, Erin R Dola, Sancy A Leachman. J Am Acad Dermatol 2009
26
34

MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Maria Concetta Fargnoli, Sara Gandini, Ketty Peris, Patrick Maisonneuve, Sara Raimondi. Eur J Cancer 2010
58
15

Melanoma: from mutations to medicine.
Hensin Tsao, Lynda Chin, Levi A Garraway, David E Fisher. Genes Dev 2012
337
9

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Robert R McWilliams, Eric D Wieben, Kari G Rabe, Katrina S Pedersen, Yanhong Wu, Hugues Sicotte, Gloria M Petersen. Eur J Hum Genet 2011
79
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.